Healthcare - Biotechnology - NASDAQ - US
$ 35.94
-2.97 %
$ 2.79 B
Market Cap
-276.46
P/E
Price Target
Average
--12.35%
Revenue Forecast
Estimate
1.82%
EBIT
Estimate
--24.17%
Net Income
Estimate
--0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Veracyte, Inc.
Wall Street analysts predict an average 1-year price target for VCYT of $31.5 , with forecasts ranging from a low of $23 to a high of $44 .
VCYT Lowest Price Target
Wall Street Target
23 USD
-36.00%
VCYT Average Price Target
Wall Street Target
31.5 USD
-12.35%
VCYT Highest Price Target
Wall Street Target
44 USD
22.43%
REVENUE FORECAST
Revenue Forecast Chart VCYT
EBIT FORECAST
EBIT Forecast Chart VCYT
NET INCOME FORECAST
Net Income Chart VCYT